Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03470428 · ClinicalTrials.gov registry record

Clinical Characteristics and Associations of the "Good Fontan" Patient

A clinical trial of Congenital Heart Disease and Single-ventricle, sponsored by Boston Children's Hospital.

Completed
Registry status
146
Enrollment target
1
Study location

NCT03470428 is a study of Congenital Heart Disease and Single-ventricle that has completed, run by Boston Children's Hospital. The registered enrollment target is 146 participants, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03470428, a study of Congenital Heart Disease and Single-ventricle, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
146 participants
Enrollment target
1
Study location

Study Summary

This study aims to determine what are some of the clinical characteristics and associations of Fontan patients who are doing well, as well as how accurate cardiology providers are at predicting the likelihood of future adverse event in their Fontan patients.

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2018-03-05
Est. Completion 2023-04-18

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT03470428

The ClinicalTrials.gov registry entry for NCT03470428 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (69% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 0 interventions.

NCT03470428 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03470428 about?

NCT03470428 is a clinical study titled "Clinical Characteristics and Associations of the "Good Fontan" Patient". This study aims to determine what are some of the clinical characteristics and associations of Fontan patients who are doing well, as well as how accurate cardiology providers are at predicting the likelihood of future adverse event in their Fontan patients.

What is the current status of trial NCT03470428?

This trial is currently completed. The enrollment target is 146 participants. The study started on 2018-03-05. Estimated completion is 2023-04-18.

What conditions does trial NCT03470428 study?

This clinical trial studies the following conditions: Congenital Heart Disease, Single-ventricle.

Who is sponsoring clinical trial NCT03470428?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03470428 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.